Empowering Cancer Care: Feasibility and Acceptance of a Digital Home-Based Health Care Monitoring System for CDK4/6 Inhibitor Therapy

被引：0
|
作者：
Huebner, Hanna [1 ,2 ,3 ]
Wurmthaler, Lena [1 ,2 ,3 ]
Goossens, Chloe [1 ,2 ,3 ]
Ernst, Mathias [1 ,2 ,3 ]
Seitz, Katharina [1 ,2 ,3 ]
Ruebner, Matthias [1 ,2 ,3 ]
Beckmann, Matthias [1 ,2 ,3 ]
Fasching, Peter Andreas [1 ,2 ,3 ]
机构：
[1] Bavarian Canc Res Ctr BZKF, Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany
[3] Friedrich Alexander Univ Erlangen Nurnbergy, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [11] Feasibility of a kinect-based system in assessing physical function of the elderly for home-based care
    Liu, Xin-Ting
    Nikkhoo, Mohammad
    Wang, Lizhen
    Chen, Carl P. C.
    Chen, Hung-Bin
    Chen, Chih-Jui
    Cheng, Chih-Hsiu
    BMC GERIATRICS, 2023, 23 (01)
  • [12] Survival according to early ctDNA dynamics in advanced breast cancer (ABC) treated with endocrine therapy (ET) and a CDK4/6 inhibitor (CDK4/6i)
    Martinez Saez, O.
    Felip Falgas, E.
    Cappelletti, M.
    Tolosa, P.
    Braso-Maristany, F.
    Sanfeliu Torres, E.
    Pascual, T.
    Chic, N.
    Vidal, M.
    Adamo, B.
    Munoz, M.
    Faull, I.
    Odegaard, J.
    Patel, G.
    McEwen, R.
    Carroll, D.
    Ciruelos, E. M.
    Generali, D. G.
    Margeli Vila, M.
    Prat, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S127 - S128
  • [13] Longitudinal, multimodal profiling of metastatic ER plus breast cancer on CDK4/6 inhibitor therapy
    Creason, Allison L.
    Egger, Julian
    Watson, Cameron
    Sivagnanam, Shamilene
    Lin, Jia-Ren
    Chin, Koei
    Sorger, Peter K.
    Coussens, Lisa M.
    Mitri, Zahi I.
    Gray, Joe W.
    Mills, Gordon B.
    Goecks, Jeremy
    CANCER RESEARCH, 2023, 83 (07)
  • [14] Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor
    Malon, Diego
    Molto, Consolacion
    Prasla, Shopnil
    Cuthbert, Danielle
    Pathak, Neha
    Berner-Wygoda, Yael
    Di Lorio, Massimo
    Li, Meredith
    Savill, Jacqueline
    Mittal, Abhenil
    Amir, Eitan
    Jhaveri, Kartik
    Nadler, Michelle B.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 210 (02) : 405 - 416
  • [15] Usability and acceptance of automated home-based symptom monitoring by urban and rural cancer patients in community-based care settings in Indiana
    Theobald, DE
    Butler, DL
    Edgerton, S
    Dugan, WM
    Cleeland, CS
    Coburn, J
    Iseminger, KA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 750S - 750S
  • [16] Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (vol 12, 5112, 2021)
    Alves, Carla L.
    Ehmsen, Sidse
    Terp, Mikkel G.
    Portman, Neil
    Tuttolomondo, Martina
    Gammelgaard, Odd L.
    Hundebol, Monique F.
    Kaminska, Kamila
    Johansen, Lene E.
    Bak, Martin
    Honeth, Gabriella
    Bosch, Ana
    Lim, Elgene
    Ditzel, Henrik J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [17] Feasibility of a Palliative Care Intervention Utilizing Community Health Workers to Facilitate Delivery of Home-based Palliative Care in India
    Cartmell, Kathleen B.
    Kenneson, Sarah Ann E.
    Roy, Rakesh
    Bhattacharjee, Gautam
    Panda, Nibedita
    Kumar, Gaurav
    Qanungo, Suparna
    INDIAN JOURNAL OF PALLIATIVE CARE, 2022, 28 (01) : 21 - 27
  • [18] Novel ERX-11 and CDK4/6 inhibitor combination therapy for treating therapy resistant breast cancer
    Viswanadhapalli, Suryavathi
    Sareddy, Gangadhara Reddy
    Ma, Shi-Hong
    Lee, Tae-Kyung
    Tekmal, Rajeshwar Rao
    Ahn, Jung-Mo
    Raj, Ganesh
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2017, 77
  • [19] Monitoring of CDK4/6 inhibitor treatment response through blood liquid biopsy in metastatic breast cancer
    Shibayama, Tomoko
    Chin, Yoon Ming
    Ono, Makiko
    Kobayashi, Takayuki
    Chan, Hiu Ting
    Hara, Fumitaka
    Hosonaga, Mari
    Kobayashi, Kokoro
    Inagaki, Rina
    Ito, Yoshinori
    Ueno, Takayuki
    Takahashi, Shunji
    Oono, Shinji
    Nakamura, Yusuke
    Low, Siew Kee
    CANCER RESEARCH, 2020, 80 (04)
  • [20] CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care
    Hui, Rina
    de Boer, Richard
    Lim, Elgene
    Yeo, Belinda
    Lynch, Jodi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 3 - 14
12345